CHICAGO, Feb. 3, 2022 /PRNewswire/ — Brown Gibbons Lang & Firm (BGL), a foremost financial commitment banking and economic advisory agency, is delighted to announce the sale of Lowenco A/S (Lowenco), a primary maker of ultra-reduced temperature (ULT) storage answers for the pharma field, to Impilo and SHS. BGL’s Healthcare & Daily life Sciences expenditure banking group initiated the transaction and acted as the special economic advisor to Lowenco. The specific conditions of the transaction were not disclosed.
BGL’s Healthcare & Lifetime Sciences workforce initiated the transaction and acted as the unique economic advisor to Lowenco.
Founded in 2013 and headquartered in Vamdrup, Denmark, Lowenco is a top maker of significant-scale ULT storage methods for biotech and pharmaceutical firms. The firm’s unique modular answers have been produced under the model names LSSU and CON20, with a steadily expanding R&D pipeline and a developing world-wide shopper foundation. Lowenco provides its custom answers around the world, where ever GMP guidelines are adopted.
The business is properly-positioned to continue on addressing the rising need for substantial scale ULT storage options, underpinned by the solid fundamental progress in biopharma volumes, leveraging its unique customer benefit proposition that is centered all around excellent good quality, overall performance and company, significantly decrease cost of ownership, and main energy efficiency. Pursuing the transaction, Lowenco’s administration crew will remain intact, led by CEO Mikael Hoier, who has been part of the management crew considering the fact that 2017.
Impilo is a Nordic investment organization focused on lengthy-term investments in sustainable healthcare firms energetic in pharmaceuticals, health-related technologies, healthcare companies and other wellness-linked regions. The acquisition of Lowenco marks Impilo’s fourth expense in Denmark. SHS, centered in Tübingen, Germany, specializes in healthcare investments and is presently investing from its fifth fund, which was released in 2018.
BGL’s Healthcare & Lifestyle Sciences team has decades of knowledge advising corporations across the diagnostics, investigation tools, lab products and unit landscape. We have provided funds development, technology approach, company ventures, and clinical machine M&A method for a wide vary of providers. Furthermore, we sustain energetic interactions with world wide market members and capital companies, and carefully follow regulatory and reimbursement tendencies. Our sector involvement permits us to not only present special obtain to capital vendors, but also discover and execute on strategic alternatives for our expenditure banking shoppers.
About Brown Gibbons Lang & Enterprise
Brown Gibbons Lang & Enterprise (BGL) is a primary independent expense lender and monetary advisory organization focused on the world-wide center industry. The organization advises personal and community businesses and personal equity groups on mergers and acquisitions, money marketplaces, monetary restructurings, valuations and thoughts, and other strategic issues. BGL has expenditure banking places of work in Chicago, Cleveland, and Philadelphia, and genuine estate places of work in Chicago, Cleveland, and San Antonio. The business is also a founding member of Worldwide M&A Companions, enabling BGL to company consumers in a lot more than 30 countries around the globe. Securities transactions are done by Brown, Gibbons, Lang & Corporation Securities, Inc., an affiliate of Brown Gibbons Lang & Enterprise LLC and a registered broker-seller and member of FINRA and SIPC. For extra information and facts, remember to go to www.bglco.com.
Check out first content to down load multimedia:https://www.prnewswire.com/information-releases/bgl-announces-the-sale-of-lowenco-to-impilo-and-shs-301475389.html
Source Brown Gibbons Lang & Company